RECURRENT CERVICAL CARCINOMA
Clinical trials for RECURRENT CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink returning gynecologic tumors
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib together with radiation therapy for people whose gynecologic cancer (like ovarian, endometrial, or cervical) has returned after previous treatment. The main goal is to find the safest dose and see how well the combination wor…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:48 UTC
-
New combo aims to revive immune attack on hard-to-treat cervical cancer
Disease control Recruiting nowThis study tests a new drug, PRGN-2009, combined with pembrolizumab in 24 adults whose recurrent or metastatic cervical cancer no longer responds to pembrolizumab alone. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have HPV-…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Tumor tissue study aims to predict cancer treatment success
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a new diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 partici…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC